Concordance of the Quotient Attention Deficit Hyperactivity Disorder (ADHD) System Report With Teacher and Parent Assessments for Symptoms of ADHD

This study has been withdrawn prior to enrollment.
(No interest from school district)
Sponsor:
Collaborator:
New Hampshire School Administrative Unit #44
Information provided by (Responsible Party):
BioBehavioral Diagnostics Company
ClinicalTrials.gov Identifier:
NCT01118650
First received: May 5, 2010
Last updated: April 17, 2012
Last verified: April 2012
  Purpose

To demonstrate concordance between the Quotient ADHD System Report and standard DSM-IV based parent and teacher reported rating/assessment scales, currently the accepted method of symptom measurement for subjects diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).


Condition
Attention Deficit Hyperactivity Disorder

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Concordance of the Quotient ADHD System Report With Teacher and Parent Assessments in School-Aged Children Receiving an Individualized Education Program (IEP) or 504 Accommodations in the Classroom Setting for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD)

Resource links provided by NLM:


Further study details as provided by BioBehavioral Diagnostics Company:

Enrollment: 0
Study Start Date: June 2010
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Detailed Description:

Public school based study for children ages 8 through 14 years of age.

Children previously identified and currently receiving an Individualized Education Program (IEP) or 504 accommodations in the classroom setting for symptoms of ADHD.

Open enrollment of 30 subjects, both male and female.

One study visit in which subjects will perform/receive the following assessments/evaluations:

  1. Quotient ADHD System Test
  2. Vanderbilt ADHD Diagnostic Teacher Rating Scale
  3. Vanderbilt ADHD Diagnostic Parent Rating Scale

The primary analytical goal is to examine the extent of agreement of the Quotient ADHD System(either individual measures or in combination) with standard measures (Vanderbilt ADHD Diagnostic Teacher Rating Scale and Vanderbilt ADHD Diagnostic Parent Rating Scale) and to compare this agreement with that seen between the standard measures.

  Eligibility

Ages Eligible for Study:   8 Years to 14 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Public School based study for children ages 8 through 14 years of age who have been identified and are currently receiving an Individualized Education Program (IEP) or 504 accommodations in the classroom setting for symptoms of Attention Deficit Hyperactivity Disorder

Criteria

Inclusion Criteria:

  • A student attending one of three public elementary schools in the New Hampshire School Administrative Unit #44.
  • Age 8 through 14 years old at time of enrollment.
  • Pre-identified as receiving an Individualized Education Program (IEP) or 504 accommodations for symptoms of ADHD in the school setting by the Special Education Coordinator in the school district.
  • A parent/guardian of the child must be willing to participate.

Exclusion Criteria:

  • No subject will be excluded from participation based on race, ethnicity, or gender. Anyone meeting inclusion criteria, who are willing to sign consent and participate, will be included in the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01118650

Sponsors and Collaborators
BioBehavioral Diagnostics Company
New Hampshire School Administrative Unit #44
Investigators
Principal Investigator: Calvin R Sumner, MD BioBehavioral Diagnostic Company
  More Information

No publications provided

Responsible Party: BioBehavioral Diagnostics Company
ClinicalTrials.gov Identifier: NCT01118650     History of Changes
Other Study ID Numbers: BBD0108
Study First Received: May 5, 2010
Last Updated: April 17, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by BioBehavioral Diagnostics Company:
Inattention
Hyperactivity
Impulsivity

Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity
Disease
Hyperkinesis
Attention Deficit and Disruptive Behavior Disorders
Dyskinesias
Mental Disorders
Mental Disorders Diagnosed in Childhood
Nervous System Diseases
Neurologic Manifestations
Pathologic Processes
Signs and Symptoms

ClinicalTrials.gov processed this record on October 23, 2014